Cantor Fitzgerald Maintains Overweight on Teradyne, Raises Price Target to $550

تيراداين إنك

Teradyne, Inc.

TER

0.00

Cantor Fitzgerald analyst C.J. Muse maintains Teradyne (NASDAQ: TER) with a Overweight and raises the price target from $400 to $550.